Vernal Keratoconjunctivitis (VKC) is a chronic, inflammatory ocular surface disease that significantly impacts patient comfort and quality of life.
This video presents real-world clinical experience with Lifitegrast (Lifanta) in managing ocular surface inflammation associated with VKC.
By : Dr. Eric Donnenfled
Subscribe to our newsletter and be the first to receive insights, updates, and expert tips on optimizing your financial management.